(NASDAQ: IVF) Invo Fertility's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 17.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.63%.
Invo Fertility's earnings in 2025 is -$29,207,197.On average, 2 Wall Street analysts forecast IVF's earnings for 2026 to be -$44,927,853, with the lowest IVF earnings forecast at -$43,593,363, and the highest IVF earnings forecast at -$46,707,174. On average, 2 Wall Street analysts forecast IVF's earnings for 2027 to be -$84,354,337, with the lowest IVF earnings forecast at -$81,848,763, and the highest IVF earnings forecast at -$87,695,103.
In 2028, IVF is forecast to generate -$9,570,091 in earnings, with the lowest earnings forecast at -$9,285,831 and the highest earnings forecast at -$9,949,105.